Cas:59643-68-4 3,5-dimethyl-3-heptene manufacturer & supplier

Chemical Name:3,5-dimethyl-3-heptene

CAS.NO:59643-68-4

Synonyms:3.5-Dimethyl-3-heptene,cis and trans;3 5-DIMETHYL-3-HEPTENE

Molecular Formula:C₉H₁₈

Molecular Weight:126.23900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:126.14100

LogP:3.38880

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3.5-Dimethyl-3-heptene,cis and trans chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3 5-DIMETHYL-3-HEPTENE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3.5-Dimethyl-3-heptene,cis and trans Use and application,3 5-DIMETHYL-3-HEPTENE technical grade,usp/ep/jp grade.

Related News: Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed. 3,5-dimethyl-3-heptene manufacturer Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality. 3,5-dimethyl-3-heptene supplier Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API. 3,5-dimethyl-3-heptene vendor In the process of fine chemical industry transfer, intermediates are a very important category, and they are also the main link for China to undertake transfers. 3,5-dimethyl-3-heptene factory Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed.